Article Details

Novo to acquire Dicerna for more than $3B amid RNA drug resurgence | BioPharma Dive

Retrieved on: 2021-11-18 13:23:46

Tags for this article:

Click the tags to see associated articles and topics

Novo to acquire Dicerna for more than $3B amid RNA drug resurgence | BioPharma Dive. View article details on hiswai:

Excerpt

Merck closed Sirna's labs, while Roche exited the field altogether, a move that sent shock waves through the field at the time. RNAi, however, has ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up